Pharmaceutical Industry Information Portal

HomePharma marketing analytics

Pharma marketing analytics

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by a low-to-mid twenties percentage, but...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in the first quarter thanks to...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong sales growth across Biopharma and...

STADA continues to outpace the market in H1 and strengthens basis for further growth

STADA again demonstrated its resilience amid challenging conditions due to the pandemic by outperforming industry trends in the first half of 2021.

Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027

In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment.

Expert Articles